Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106497843B reveals high-purity biocatalytic route. Reduces costs and enhances supply chain reliability for diabetes drug intermediates.
Patent CN117467631B reveals novel P450 mutant for gamma-lactone. Enables cost reduction in fine chemical manufacturing with high selectivity.
Patent CN1946665A reveals a THF-based route for 3-cyclopentyloxy-4-methoxybenzaldehyde, enabling in-situ usage and significant cost reduction in pharma manufacturing.
Patent CN101857613A reveals a novel PTC synthesis for anti-influenza rupestonic acid esters, offering cost reduction in API manufacturing and scalable production.
Novel biocatalytic route for (R)-1-(4-bromophenyl)-2,2,2-trifluoroethanol using Cyberlindnera saturnus. High ee, mild conditions, scalable pharma intermediate production.
Patent CN113462728A details a novel whole-cell biocatalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112048538B reveals a high-yield biocatalytic route for Aprepitant intermediates using Cyberlindnera saturns, offering superior purity and cost efficiency.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN104610226A reveals a novel asymmetric oxidation method for dexlansoprazole intermediates, offering high purity and scalable supply chain advantages for global pharmaceutical manufacturers.
Novel solid acid catalyst process reduces waste and cost for cosmetic UV absorber manufacturing ensuring supply chain stability and high purity specifications.
Patent CN112877386B details a novel enzymatic route for NMN. This report analyzes cost reduction in nutritional ingredients manufacturing and supply chain reliability.
Patent CN101547890A details a catalytic asymmetric synthesis of primary amines using spiroboronic esters, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105622609B reveals a micron-order sodium carbonate method for high-purity Linagliptin. This technical insight details cost reduction and supply chain reliability for API manufacturing.
Patent CN113754673A details a green enzymatic route for indoline isochroman derivatives, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN106906192A reveals high-efficiency microbial glucosyltransferase for crocetin ester synthesis. Offers superior yield and supply chain stability for pharmaceutical intermediates.
Novel carbonyl reductase mutants enhance thermal stability and yield for pharmaceutical intermediates like florfenicol and statins, offering cost-effective biocatalytic solutions.
Patent CN104254538A reveals stable boronated derivatives enabling scalable Suzuki coupling for high-performance organic semiconductor materials and display applications.
Novel patent CN105061234A offers high-purity pregabalin route. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN1852887A details a novel asymmetric copper complex for high-selectivity cyclopropanation, offering cost reduction in pyrethroid manufacturing and reliable supply chain solutions.
Patent CN104630242B reveals novel biocatalytic routes for chiral intermediates. Enhances supply chain reliability and reduces heavy metal dependency in manufacturing.